Healthcare Industry News: HSMN NewsFeed
News Release - December 21, 2017
PENTAX Medical Appoints Veteran Executive As The Americas Region President And CEOMONTVALE, N.J., Dec. 21, 2017 -- (Healthcare Sales & Marketing Network) -- PENTAX Medical, a healthcare industry leader in endoscopy solutions, announced that David Woods, the current Global Chief Marketing Officer of PENTAX Medical, has been appointed President of PENTAX Medical of the Americas, effective immediately.
In this role, Mr. Woods will provide leadership, vision, and strategic direction for the operating units in the Pan-American region. He will also continue his role in Global Strategy, focused on organic product development and mergers and acquisitions. Mr. Woods will continue to report directly to Gerald W. Bottero, Global President of PENTAX Medical.
"I have personally witnessed David's vision, passion, and energy, and I am very excited about our future as we enter the new year," stated Bottero. "During his nearly two decades at PENTAX Medical, David has assembled an impressive track record of strategic and commercial accomplishments. He is a respected leader who combines passion and commitment with extensive industry experience and I am certain he will be instrumental in driving the next era of growth, operational excellence and customer satisfaction at PENTAX Medical."
Mr. Woods is an industry veteran with over 20 years' experience in the healthcare sector. He began his career at PENTAX Medical in 1998 as the Director of National Accounts and was promoted to Vice President of Business Development in 2001. In 2004, he became President of the Americas region, a role he successfully fulfilled for more than 10 years. Recently, in 2015, Mr. Woods was promoted to Global Chief Marketing Officer, where he led product strategy, management, marketing, and mergers and acquisitions. Mr. Woods has been instrumental in PENTAX Medical's investment in Creo Medical, the acquisition of C2 Therapeutics, establishment of the China joint venture with Shanghai Aohua Photoelectricity Endoscope Co., and launch of the PENTAX Medical Triple Aim Partnership model that is focused on improved clinical and economic outcomes, and enhanced patient and provider satisfaction.
"I am honored to be taking on the role of President and CEO of the Americas," said Mr. Woods. "Our product development strategy, encompassing internal development and acquisitions, will help PENTAX Medical deliver value to our customers based on their input and concern for their patients. I am excited to work with many long-time friends and colleagues in the gastroenterology field to improve patient health and outcomes."
About PENTAX Medical
PENTAX Medical is a division of Hoya Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading-edge R&D and manufacturing, PENTAX Medical provides endoscopy solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe. PENTAX Medical employees represent the diverse countries where we do business, allowing us to provide innovative solutions tailored to meet local needs.
Source: PENTAX Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsPENTAX Medical acquires majority stake in PlasmaBiotics SAS, a technology innovator focused on the ultra-fast channel drying and active storage of endoscopes
Avantis Medical Names Matt Frushell as President and CEO, Salmaan Hameed as CTO, as Company Moves to Full Commercial Operation
PENTAX Medical Introduces Next-Generation C2 CryoBalloon(TM) Ablation System for Treatment of Barrett's Esophagus